Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy

Sharon Grisaru-Tal, Marc E. Rothenberg, Ariel Munitz

نتاج البحث: نشر في مجلةمقالةمراجعة النظراء


Eosinophils are important effector cells and therapeutic targets in allergic diseases. Emerging data indicate that eosinophils infiltrate a variety of solid tumor types and have pleiotropic activities by at least two non-mutually exclusive mechanisms: direct interactions with tumor cells, and intricate cross-talk with lymphocytes. In light of the immune checkpoint inhibition revolution in cancer therapy, we review eosinophil–lymphocyte interactions in the tumor microenvironment. We also analyze potential interactions between eosinophils and lymphocyte subsets, including T cells, natural killer cells and innate lymphoid cells. We provide perspectives on the consequences of these interactions and how eosinophils are accessory cells that can affect the response to various forms of T cell-mediated immunotherapies and might be therapeutically targeted to improve cancer immunotherapy.

اللغة الأصليةالإنجليزيّة
دوريةNature Immunology
المعرِّفات الرقمية للأشياء
حالة النشرنُشِر - سبتمبر 2022

All Science Journal Classification (ASJC) codes

  • !!Immunology and Allergy
  • !!Immunology


أدرس بدقة موضوعات البحث “Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا